Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Omega-3 fatty acids for bipolar disorder
Your Article Summary
A safety and tolerability laboratory study of the combination of aripiprazole and topiramate in volunteers who drink alcohol
Human Psychopharmacology: Clinical and Experimental, 06/26/09
Kenna GA et al. - There was no evidence that AEs of aripiprazole and topiramate are additive and can, therefore, be administered safely together with a modest amount of alcohol. There was also a trend for a reduction of alcohol use by participants. This finding has implications for further investigation of this combination of drugs for alcohol dependence.
Methods- Thirteen heavy drinking participants not seeking treatment for alcoholism were randomized.
- Participants were titrated up to 300 mg of topiramate and 30 mg of aripiprazole a day over 35 days.
- Participants reported adverse events (AEs) daily alcohol use and participated in an alcohol challenge session (ACS).
- The eight participants who completed the study achieved the maximum doses of drugs.
- The AEs of the drugs would suggest that the AEs profile is broader but not additive.
- Alcohol use from the 28 days before screening to the seven days before the ACS was reduced (p = 0.08).
Related Articles
Aripiprazole versus other atypical antipsychotics for schizophrenia
Cochrane Reviews, 10/21/09
Relevance Score: 46%
Topiramate in migraine progression
The Journal of Headache and Pain, 10/21/09
Relevance Score: 45%
Pharmacological and combined interventions for the acute depressive episode: focus on efficacy and tolerability
Therapeutics and Clinical Risk Management, 11/17/09
Relevance Score: 43%
Topiramate overdose: A case report of a patient with extremely high topiramate serum concentrations and nonconvulsive status epilepticus
Epilepsia, 11/11/09
Relevance Score: 43%
Topiramate for Migraine Prevention in a Naturalistic Setting: Results From an Open Label, Flexible Dose Study
Headache: The Journal of Head and Face Pain, 10/07/09
Relevance Score: 43%
Today in Mood Disorders...keeping you current
Receive free subspecialty "5-minute updates" via email
Increased Cold-Pain Thresholds in Major Depression
The Journal of Pain, 12/02/09
Low Respiratory Function Increases the Risk of Depressive Symptoms in Later Life in Men
Psychosomatic Medicine, 12/02/09
Mindfulness-Based Attention as a Moderator of the Relationship Between Depressive Affect and Negative Cognitions
Cognitive Therapy and Research, 12/02/09
Today in Neuro/Psych Pharmacol...keeping you current
Receive free subspecialty "5-minute updates" via email
Risperidone long acting injection: Findings of a 2-year retrospective follow-up study
International Journal of Psychiatry in Clinical Practice, 12/02/09
Olanzapine for the Treatment of Acquired Neurogenic Stuttering
Journal of Psychiatric Practice, 12/02/09
The effect of atypical antipsychotics on pituitary gland volume in patients with first-episode psychosis: A longitudinal MRI study
Schizophrenia Research, 12/02/09
Today in Schizophrenia/Psychosis...keeping you current
Receive free subspecialty "5-minute updates" via email
Risperidone long acting injection: Findings of a 2-year retrospective follow-up study
International Journal of Psychiatry in Clinical Practice, 12/02/09
The effect of atypical antipsychotics on pituitary gland volume in patients with first-episode psychosis: A longitudinal MRI study
Schizophrenia Research, 12/02/09
Correspondences between theory of mind, jumping to conclusions, neuropsychological measures and the symptoms of schizophrenia
Psychiatry Research, 12/02/09
Sponsor
Article Search
Sponsor


See Latest Articles


